BY FROMA HARROP Drugmakers rang in the new year by raising prices on hundreds of products – American prices, that is. Americans focused on the celebrations weren’t paying attention. Allergan led the parade, hiking its prices by 10% on more than two dozen drugs. But note this: It didn’t raise the price of Botox, the anti-wrinkle treatment. Why? Because most users of Botox pay for it out of pocket. They can say, “I’m not bearing […]
To access this content, you must log in or purchase PRINT ONLY - The Oklahoma Observer Print Edition, DIGITAL ONLY - The Oklahoma Observer on-line or TOTAL ACCESS - The Oklahoma Observer on-line and in print
